{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:35:09Z","timestamp":1761744909218,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.dsx.2021.102246","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T03:18:49Z","timestamp":1628824729000},"page":"102246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome"],"prefix":"10.1016","volume":"15","author":[{"given":"Subhadeep","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3809-8926","authenticated-orcid":false,"given":"Atanu","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biman Kanti","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alak","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.dsx.2021.102246_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2021.102246_bib2","article-title":"Anticoagulation in COVID-19: current concepts and controversies","author":"Chandra","year":"2021","journal-title":"Postgrad Med"},{"issue":"6","key":"10.1016\/j.dsx.2021.102246_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.dsx.2021.102246_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/ane.13266","article-title":"Neurological Manifestations of COVID-19: a systematic review and current update","volume":"142","author":"Whittaker","year":"2020","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10.1016\/j.dsx.2021.102246_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-238668","article-title":"COVID-19-associated acute transverse myelitis: a rare entity","volume":"13","author":"Chakraborty","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.dsx.2021.102246_bib6","first-page":"191","article-title":"Guillain-Barr\u00e9 syndrome","volume":"87","author":"Walling","year":"2013","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.dsx.2021.102246_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism","volume":"25","author":"Lucchese","year":"2020","journal-title":"Cell Stress Chaperones"},{"issue":"5","key":"10.1016\/j.dsx.2021.102246_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.dsx.2021.102246_bib9","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.dsx.2021.102246_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s41983-021-00310-7","article-title":"Guillain-Barre syndrome in 220 patients with COVID-19","volume":"57","author":"Finsterer","year":"2021","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"issue":"4","key":"10.1016\/j.dsx.2021.102246_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.dsx.2021.102246_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.33588\/rn.7206.2020487","article-title":"Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports","volume":"72","author":"Zuberb\u00fchler","year":"2021","journal-title":"Rev Neurol"},{"key":"10.1016\/j.dsx.2021.102246_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/jnnp.64.2.242","article-title":"Risk factors for treatment related clinical fluctuations in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 study group","volume":"64","author":"Visser","year":"1998","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.dsx.2021.102246_bib14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z","article-title":"Relapses in the Guillain-Barr\u00e9 syndrome after treatment with intravenous immune globulin or plasma exchange","volume":"21","author":"Romano","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.dsx.2021.102246_bib15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain-barr\u00e9 syndrome: epidemiology, pathophysiology and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121002666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121002666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:17:02Z","timestamp":1761729422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121002666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1871402121002666"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102246","relation":{},"ISSN":["1871-4021"],"issn-type":[{"type":"print","value":"1871-4021"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102246"}}